Identification of ace inhibitory cryptides in Tilapia protein hydrolysate by UPLC–MS/MS coupled to database analysis

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 1052, Issue , 2017, Pages 43-50

  Yesmine, Ben Henda ^a   Antoine, Bonnet ^a   da Silva Ortência Leocádia, Nunes Gonzalez ^b   Rogério, Boscolo Wilson ^b   Ingrid, Arnaudin ^a   Nicolas, Bridiau ^a   Thierry, Maugard ^a   Piot, Jean Marie ^a   Frédéric, Sannier ^a   Stéphanie, Bordenave Juchereau ^a  

^a UNIVERSITÉ DE LA ROCHELLE   (France)

^b UNIVERSIDADE ESTADUAL DO OESTE DO PARANÁ   (Brazil)

Author keywords

ACE; Cryptides; Database; MS MS; Tilapia protein hydrolysate; UPLC

Indexed keywords

DATABASE SYSTEMS; HYDROLYSIS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PEPTIDES;

ANGIOTENSIN I-CONVERTING ENZYME; CRYPTIDES; MOLECULAR WEIGHT FRACTION; MS/MS; OREOCHROMIS NILOTICUS; PROTEIN HYDROLYSATE; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY QUADRUPOLE TIME OF FLIGHT MASS SPECTROMETRIES; UPLC;

PROTEINS;

DIPEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE; PROTEIN HYDROLYSATE; TRIPEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FISH PROTEIN; PEPTIDE;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; ENZYME INHIBITION; FREEZE DRYING; HYDROPHOBICITY; IC50; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; MOLECULAR WEIGHT; NONHUMAN; OREOCHROMIS NILOTICUS; PRIORITY JOURNAL; QUADRUPOLE MASS SPECTROMETRY; TANDEM MASS SPECTROMETRY; TIME OF FLIGHT MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ULTRAFILTRATION; ANIMAL; CHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOLATION AND PURIFICATION; METABOLISM; RABBITS AND HARES; TILAPIA;

AMINO ACID SEQUENCE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FISH PROTEINS; PEPTIDES; PEPTIDYL-DIPEPTIDASE A; RABBITS; TANDEM MASS SPECTROMETRY; TILAPIA;

EID: 85016139834     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2017.02.015     Document Type: Article

References (35)

1. [1] Ben Henda, Y., Bordenave-Juchereau, S., Using marine cryptides against metabolic syndrome. Hernández-Ledesma, B., Herrero, M., (eds.) Bioactive Compounds from Marine Foods: Plant and Animal Sources, 2013, John Wiley & Sons Ltd, Chichester, UK, 95–108.
2. [2] Jimsheena, V.K., Gowda, L.R., Arachin derived peptides as selective angiotensin I-converting enzyme (ACE) inhibitors: structure–activity relationship. Peptides 31 (2010), 1165–1176.
3. [3] Harnedy, P.A., FitzGerald, J.A., Bioactive peptides from marine processing waste and shellfish: a review. J. Funct. Foods. 4 (2012), 6–24.
4. [4] Kim, S.K., Wijesekara, I., Development and biological activities of marine-derived bioactive peptides: a review. J. Funct. Foods. 2 (2010), 1–9.
5. [5] Ng, W.K., Romano, N., A review of the nutrition and feeding management of farmed tilapia throughout the culture cycle. Rev. Aquac. 5 (2013), 220–254.
6. [6] Huang, B.B., Lin, H.C., Chang, Y.W., Analysis of proteins and potential bioactive peptides from tilapia (Oreochromis spp) processing s using proteomic techniques coupled with BIOPEP database. J. Funct. foods. 19 (2015), 629–640.
7. [7] Halim, N.R.A., Yusof, H.M., Sarbon, N.M., Functional and bioactive properties of fish protein hydrolysates and peptides: a comprehensive review. Trends Food Sci. Technol. 51 (2016), 24–33.
8. [8] Panchaud, A., Affolter, M., Kussmann, M., Mass spectrometry for nutritional peptidomics: how to analyze food bioactives and their health effects. J. Proteomics 75:12 (2012), 3546–3559 27.
9. [9] Saavedra, L., Hebert, E., Minahk, C., Ferranti, P., An overview of omic analytical methods applied in bioactive peptide studies. Food Res. Int. 54 (2013), 925–934.
10. [10] Silveira, S.T., Martínez-Maqueda, D., Recio, I., Hernández-Ledesma, B., Dipeptidyl peptidase-IV inhibitory peptides generated by tryptic hydrolysis of a whey protein concentrate rich in β-lactoglobulin. Food Chem. 141:2 (2013), 1072–1077 15.
11. [11] Ben Henda, Y., Labidi, A., Arnaudin, I., Bridiau, N., Delatouche, R., Maugard, T., Piot, J.M., Sannier, F., Thiéry, V., Bordenave-Juchereau, S., Measuring angiotensin-I converting enzyme inhibitory activity by micro plate assays: comparison using marine cryptides and tentative threshold determinations with captopril and losartan. J. Agric. Food Chem. 61 (2013), 10685–10690.
12. [12] Ben Henda, Y., Laamari, M., Lanneluc, I., Travers, M.A., Agogué, H., Arnaudin, I., Bridiau, N., Maugard, T., Piot, J.M., Sannier, F., Bordenave-Juchereau, S., Di and tripeptides from marine sources can target adipogenic process and contribute to decrease adipocyte number and functions. J. Funct. Foods 17 (2015), 1–10.
13. [13] Bradford, M.M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976), 248–254 7.
14. [14] Minkiewicz, P., Dziuba, J., Iwaniak, A., Dziuba, M., Darewicz, M., BIOPEP database and other programs for processing bioactive peptide sequences. J. AOAC Int. 91 (2008), 965–980 http://www.uwm.edu.pl/biochemia/index.php/pl/biopep.
15. [15] Wu, J., Ding, X., Characterization of inhibition and stability of soy-protein-derived angiotensin I-converting enzyme inhibitory peptides. Food Res. Int. 35:4 (2002), 367–375.
16. [16] Pilhanto-Leppälä, A., Koskinen, P., Piilola, K., Tupasela, T., Korhonen, H., Angiotensin I-converting enzyme inhibitory properties of whey protein digests: concentration and characterization of active peptides. J. Dairy Res. 67:01 (2000), 53–64.
17. [17] Jung, W.K., Mendis, E., Je, J.Y., Park, P.J., Son, B.W., Kim, H.C., Choi, Y.K., Kim, S.K., Angiotensin I-converting enzyme inhibitory peptide from yellowfin sole (Limanda aspera) frame protein and its antihypertensive effect in spontaneously hypertensive rats. Food Chem. 94:1 (2004), 26–32 6.
18. [18] Jeon, Y.J., Byun, H.G., Kim, S.K., Improvement of functional properties of cod frame protein hydrolysates using ultrafiltration membranes. Process Biochem. 35:5 (1999), 471–478.
19. [19] Fujii, M., Matshumura, N., Mito, K., Shimizu, T., Kuwahara, M., Sugana, S., Karaki, H., Antihypertensive Effects of peptides in autolysate of bonito bowels on spontaneously hypertensive rats. Biosci. Biotechnol. Biochem. 57:12 (1993), 2186–2188.
20. [20] Raghavan, S., Kristinsson, H.G., ACE-inhibitory activity of tilapia protein hydrolysates. Food Chem. 117 (2009), 582–588.
21. [21] Matsufuji, H., Matsui, T., Seki, E., Osajima, K., Nakashima, M., Osajima, Y., Angiotensin I-converting enzyme inhibitory peptides in an alkaline protease hydrolyzate derived from sardine muscle. Biosci. Biotechnol. Biochem. 58 (1994), 2244–2245.
22. [22] Fahmi, A., Morimura, S., Guo, H.C., Shigematsu, T., Kida, K., Uemura, Y., Production of angiotensin I converting enzyme inhibitory peptides from sea bream scales. Process Biochem. 39 (2004), 1195–1200.
23. [23] Suetsuna, K., Maekawa, K., Chen, J.R., Antihypertensive effects of Undaria pinnatifida (wakame) peptide on blood pressure in spontaneously hypertensive rats. J. Nutr. Biochem. 15 (2004), 267–272.
24. [24] Saito, Y., Wanezaki, K., Kawato, A., Imayasu, S., Antihypertensive effects of peptide in sake and its by-products on spontaneously hypertensive rats. Biosci. Biotechnol. Biochem. 58 (1994), 812–816.
25. [25] Marczak, E.D., Usui, H., Fujita, H., Yang, Y., Yokoo, M., Lipkowski, A.W., Yoshikawa, M., New antihypertensive peptides isolated from rapeseed. Peptides 24 (2003), 791–798.
26. [26] Matsui, T., Tamaya, K., Seki, E., Osajima, K., Matsumo, K., Kawasaki, T., Absorption of Val-Tyr with in vitro angiotensin I-converting enzyme inhibitory activity into the circulating blood system of mild hypertensive subjects. Biol. Pharm. Bull. 25 (2002), 1228–1230.
27. [27] Kawasaki, T., Seki, E., Osajima, K., Yoshida, M., Asada, K., Matsui, T., Osajima, Y., Antihypertensive effect of valyl-tyrosine a short chain peptide derived from sardine muscle hydrolyzate, on mild hypertensive subjects. J. Hum. Hypertens. 14 (2000), 519–523.
28. [28] O'Keeffe, M.B., FitzGerald, R.J., Identification of short peptide sequences in complex milk protein hydrolysates. Food Chem. 184 (2015), 140–146.
29. [29] Armirotti, A., Millo, E., Damonte, G., How to discriminate between leucine and isoleucine by low energy ESI-TRAP MSn. J. Am. Soc. Mass Spectrom. 18 (2007), 57–63.
30. [30] Byun, H.G., Kim, S.K., Purification and characterisation of angiotensin-I-converting enzyme (ACE) inhibitory peptides from Alaska pollack (Theragra chalcogramma) skin. Process Biochem. 36 (2001), 1155–1162.
31. [31] Cheung, H.S., Wang, F.L., Ondetti, M.A., Sabo, E.F., Cushman, D.W., Binding of peptide substrates and inhibitors of angiotensin-converting enzyme. Importance of the COOH-terminal dipeptide sequence. J. Biol. Chem. 255 (1980), 401–407.
32. [32] Ondetti, M.A., Cushman, D.W., Enzymes of the renin-angiotensin system and their inhibitors. Annu. Rev. Biochem. 51 (1982), 283–308.
33. [33] Gòmez-Ruiz, J.A., Recio, I., Belloque, J., ACE-inhibitory activity and structural properties of peptide Asp-Lys-Ile-His-Pro [beta-CN f(47–51)]. Study of the peptide forms synthesized by different methods. J. Agric. Food Chem. 52:20 (2004), 6315–6319.
34. [34] Wu, J., Aluko, R.E., Nakai, S., Structural requirements of Angiotensin I-converting enzyme inhibitory peptides: quantitative structure-activity relationship study of di- and tripeptides. J Agric. Food Chem. 54:3 (2006), 732–738.
35. [35] Kyte, J., Doolittle, R.F., A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157 (1982), 105–132.